Comparative Bioavailability of Betamethasone Oral Solution Metered Spray (GTX-102) in Healthy Subjects
Clinical trial NCT05531890 · UNKNOWN
Trial details
- NCT number
- NCT05531890
- Sponsor
- Grace Therapeutics Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-13
- Primary completion
- 2022-11-24
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.